Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Description
Keywords
Is Part Of
Publisher
BioMed Central
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as Attribution 4.0 International (CC BY 4.0)